Documentos relacionados

1. [Clinical phenotypes and genetic features of families with Duchenne muscular dystrophy].
2. Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice.
3. In-Frame Deletion of Dystrophin Exons 8-50 Results in DMD Phenotype.
4. Disease Heritability Studies Harness the Healthcare System to Achieve Massive Scale.
5. Partial Restoration of Brain Dystrophin and Behavioral Deficits by Exon Skipping in the Muscular Dystrophy X-Linked (mdx) Mouse.
6. mCherry on Top: A Positive Read-Out Cellular Platform for Screening DMD Exon Skipping Xenopeptide-PMO Conjugates.
7. Specificities of the DMD Gene Mutation Spectrum in Russian Patients.
8. Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot.
9. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy.
10. Molecular Fingerprint of BMD Patients Lacking a Portion in the Rod Domain of Dystrophin.